Skip to main content
. 2005 Aug 5;9(5):R508–R515. doi: 10.1186/cc3786

Table 4.

Serious adverse events

Adverse event Control Group A Group B
Deaths 7 5 10
Nosocomial infection 21 22 26
Heart rate and rhythm disorders 3 2 2
Thrombocytosis 1 - 1
Deep vein thrombosis 2 - 1
Central nervous system disorders (new ischaemic or haemorrhagic stroke) 3 2 2